Works matching DE "MYELOPROLIFERATIVE neoplasms"
Results: 2618
Evolution of WHO diagnostic criteria in "Classical Myeloproliferative Neoplasms" compared with the International Consensus Classification.
- Published in:
- Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01235-7
- By:
- Publication type:
- Article
Correction to: ETV6::ABL1 fusion: from overlooked minor clone in myeloproliferative neoplasm to major player in leukemic transformation.
- Published in:
- 2025
- By:
- Publication type:
- Correction Notice
Myeloid neoplasms with PHF6 mutations: context-dependent genomic and prognostic characterization in 176 informative cases.
- Published in:
- Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01231-x
- By:
- Publication type:
- Article
Suppressed activation of the IRF7 and TLR9 by JAK2V617F gold nanoparticles.
- Published in:
- Immunogenetics, 2025, v. 77, n. 1, p. 1, doi. 10.1007/s00251-025-01374-y
- By:
- Publication type:
- Article
How I diagnose and treat patients in the pre-fibrotic phase of primary myelofibrosis (pre-PMF) - practical approaches of a German expert panel discussion in 2024.
- Published in:
- Annals of Hematology, 2025, v. 104, n. 1, p. 295, doi. 10.1007/s00277-025-06191-7
- By:
- Publication type:
- Article
Spleen volume assessment in Ph-negative chronic myeloproliferative neoplasms: a real-life study comparing ultrasonography vs. magnetic resonance imaging scans.
- Published in:
- Annals of Hematology, 2025, v. 104, n. 1, p. 383, doi. 10.1007/s00277-024-06177-x
- By:
- Publication type:
- Article
Whole exome sequencing analysis of a patient with myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions with ETV6::LYN fusion gene.
- Published in:
- Annals of Hematology, 2025, v. 104, n. 1, p. 809, doi. 10.1007/s00277-024-06135-7
- By:
- Publication type:
- Article
Impact of the clinical nurse specialist role for the myeloproliferative neoplasm program: Part Two -- The team and patient care experiences.
- Published in:
- Canadian Oncology Nursing Journal, 2025, v. 35, n. 1, p. 71, doi. 10.5737/2368807635171
- By:
- Publication type:
- Article
Impact of the clinical nurse specialist role for the myeloproliferative neoplasm program: Part One -- From timeliness of triage to cost-saving.
- Published in:
- Canadian Oncology Nursing Journal, 2025, v. 35, n. 1, p. 53, doi. 10.5737/2368807635153
- By:
- Publication type:
- Article
Bone metabolism during interferon-alpha treatment of essential thrombocythemia.
- Published in:
- Wiener Klinische Wochenschrift, 2004, v. 116, n. 1/2, p. 37, doi. 10.1007/BF03040422
- By:
- Publication type:
- Article
Dental Implant Placement in a Patient With Polycythemia Vera: A Case Report.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
Neoplasias malignas en pelvis y su resección.
- Published in:
- Acta Ortopédica Mexicana, 2009, v. 23, n. 4, p. 237
- By:
- Publication type:
- Article
Use of CD9 and CD61 for the characterization of AML-M7 by flow cytometry in a dog<sup>*</sup> Use of CD9 and CD61 for the characterization of AML-M7 by flow cytometry in a dog.
- Published in:
- Veterinary & Comparative Oncology, 2012, v. 10, n. 4, p. 312, doi. 10.1111/j.1476-5829.2011.00290.x
- By:
- Publication type:
- Article
Difficulty distinguishing essential thrombocythaemia from polycythaemia vera in children with JAK2 V617F‐positive myeloproliferative neoplasms.
- Published in:
- Angewandte Chemie, 2019, v. 131, n. 15, p. 136, doi. 10.1111/bjh.15386
- By:
- Publication type:
- Article
Juvenile Myelomonocytic Leukemia: Report of Seven Cases and Review of Literature.
- Published in:
- Pediatric & Developmental Pathology, 2009, v. 12, n. 2, p. 136, doi. 10.2350/08-04-0456.1
- By:
- Publication type:
- Article
Computational modeling and in vitro evaluation identified natural product—Z218 as a novel Janus kinase 2 (JAK2) inhibitor to combat β‐thalassemia.
- Published in:
- Biotechnology & Applied Biochemistry, 2023, v. 70, n. 4, p. 1450, doi. 10.1002/bab.2459
- By:
- Publication type:
- Article
Screening JAK2 V617F Mutation in Acute Myeloid Leukemia (AML) and Acute Lymphoblastic Leukemia (ALL) Patients.
- Published in:
- Magazine of Al-Kufa University for Biology, 2024, v. 16, n. 3, p. 35, doi. 10.36320/ajb/v16.i3.17071
- By:
- Publication type:
- Article
Essential Thrombocythemia Following Immune Thrombocytopenia With JAK2 V617F Mutation: A Case Report.
- Published in:
- Case Reports in Clinical Practice, 2021, v. 6, n. 4, p. 141
- By:
- Publication type:
- Article
PDQ (Physician Data Query).
- Published in:
- 2013
- Publication type:
- Abstract
JAK2 Inhibitors: Not the Next Imatinib But Researchers See Other Possibilities.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2009, v. 101, n. 14, p. 980, doi. 10.1093/jnci/djp216
- By:
- Publication type:
- Article
PTEN takes center stage in cancer stem cell research, works as tumor suppressor.
- Published in:
- 2006
- By:
- Publication type:
- journal article
Protein disulfide isomerase in Philadelphia-negative myeloproliferative neoplasms: a case–control study.
- Published in:
- Egyptian Journal of Internal Medicine, 2025, v. 37, n. 1, p. 1, doi. 10.1186/s43162-025-00410-3
- By:
- Publication type:
- Article
Malignancy in Children with Trisomy 21.
- Published in:
- Oncologist, 2009, v. 14, n. 2, p. 164, doi. 10.1634/theoncologist.2008-0217
- By:
- Publication type:
- Article
Advances in the Therapy of Chronic Idiopathic Myelofibrosis.
- Published in:
- Oncologist, 2006, v. 11, n. 8, p. 929, doi. 10.1634/theoncologist.11-8-929
- By:
- Publication type:
- Article
Headache and vision loss in a middle-aged women.
- Published in:
- 2019
- By:
- Publication type:
- Case Study
Effectiveness of Ropeginterferon Alfa-2B in High-Risk Patients with Philadelphia Chromosome Negative Myeloproliferative Neoplasms– Evaluation of Clinicohaematologic Response, and Safety Profile: Single Centre Experience.
- Published in:
- Contributions / Prilozi (1857-9345), 2023, v. 44, n. 3, p. 57, doi. 10.2478/prilozi-2023-0047
- By:
- Publication type:
- Article
In vitro studies of the anti-inflammatory activity of micheliolide on myeloproliferative neoplasm cell lines.
- Published in:
- Journal of Beijing University of Traditional Chinese Medicine, 2025, v. 48, n. 1, p. 1, doi. 10.3969/j.issn.1006-2157.2025.01.009
- By:
- Publication type:
- Article
FOXP1 Expression in Normal and Neoplastic Erythroid and Myeloid Cells.
- Published in:
- Collegium Antropologicum, 2015, v. 39, n. 3, p. 755
- By:
- Publication type:
- Article
Myeloid Sarcoma Involving the Breast.
- Published in:
- Collegium Antropologicum, 2010, v. 34, n. 2, p. 641
- Publication type:
- Article
Juvenile Myelomonocytic Leukemia with PTPN11 Mutation in a 23-Month-Old Girl.
- Published in:
- Collegium Antropologicum, 2010, v. 34, n. 1, p. 251
- By:
- Publication type:
- Article
PROMOTER DNA METHYLATION OF E-CADHERIN GENE IN MOLECULAR PATHOGENESIS OF ADHESIVE COMPLEX AND ACTIVATION OF EMT MARKERS SNAIL AND TWIST1 IN MYELOPROLIFERATIVE LEUKEMIA.
- Published in:
- Bulletin of Taras Shevchenko National University of Kyiv / Vestnik Kievskogo Nacional'Nogo Universiteta Imeni Tarasa Ševčenko, 2013, v. 64, n. 2, p. 7
- By:
- Publication type:
- Article
Angioimmunoblastic T-cell Lymphoma Presenting With a Neutrophilic Leukemoid Reaction: A Diagnostic Challenge.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
Calreticulin Mutations in Myeloproliferative Neoplasms Patients Diagnosed in UKM Medical Centre.
- Published in:
- Malaysian Journal of Medicine & Health Sciences, 2023, v. 19, n. 2, p. 48, doi. 10.47836/mjmhs19.2.9
- By:
- Publication type:
- Article
Histological diversity of vasculitic lesions in MPO–ANCA-positive autopsy cases.
- Published in:
- Pathology International, 2001, v. 51, n. 6, p. 460, doi. 10.1046/j.1440-1827.2001.01225.x
- By:
- Publication type:
- Article
Thrombosis in myeloproliferative neoplasms: a viewpoint on its impact on myelofibrosis, mortality, and solid tumors.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01169-6
- By:
- Publication type:
- Article
Non-canonical FLT3 alterations reveal novel germline FLT3 variants leading to somatic gene rescue mutations.
- Published in:
- 2024
- By:
- Publication type:
- Letter
Correction to: Preclinical studies of Flonoltinib Maleate, a novel JAK2/FLT3 inhibitor, in treatment of JAK2<sup>V617F</sup>-induced myeloproliferative neoplasms.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Age-stratified analysis reveals arterial thrombosis as a predictor for gender-related second cancers in myeloproliferative neoplasms: a case-control study.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01052-4
- By:
- Publication type:
- Article
Neutrophil-to-lymphocyte ratio and all-cause mortality with and without myeloproliferative neoplasms—a Danish longitudinal study.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-00994-z
- By:
- Publication type:
- Article
Neutrophil-to-lymphocyte ratio and all-cause mortality with and without myeloproliferative neoplasms—a Danish longitudinal study.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-00994-z
- By:
- Publication type:
- Article
One thousand patients with essential thrombocythemia: the Florence-CRIMM experience.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-023-00968-7
- By:
- Publication type:
- Article
Genomic and functional impact of Trp53 inactivation in JAK2V617F myeloproliferative neoplasms.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-023-00969-6
- By:
- Publication type:
- Article
SRSF2 mutation reduces polycythemia and impairs hematopoietic progenitor functions in JAK2V617F-driven myeloproliferative neoplasm.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00947-y
- By:
- Publication type:
- Article
Cellular aging is accelerated in the malignant clone of myeloproliferative neoplasms.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00936-1
- By:
- Publication type:
- Article
Blast phase myeloproliferative neoplasm: contemporary review and 2024 treatment algorithm.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00878-8
- By:
- Publication type:
- Article
Targeting PP2A-dependent autophagy enhances sensitivity to ruxolitinib in JAK2<sup>V617F</sup> myeloproliferative neoplasms.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00875-x
- By:
- Publication type:
- Article
CPX-351 (Vyxeos™) treatment in blast-phase myeloproliferative neoplasm (MPN-BP): real-world experience in 12 consecutive cases.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00800-2
- By:
- Publication type:
- Article
Impaired humoral and T cell response to vaccination against SARS-CoV-2 in chronic myeloproliferative neoplasm patients treated with ruxolitinib.
- Published in:
- 2022
- By:
- Publication type:
- Letter
Preclinical studies of Flonoltinib Maleate, a novel JAK2/FLT3 inhibitor, in treatment of JAK2<sup>V617F</sup>-induced myeloproliferative neoplasms.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 3, p. 1, doi. 10.1038/s41408-022-00628-2
- By:
- Publication type:
- Article
Myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T): Mayo-Moffitt collaborative study of 158 patients.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 2, p. 1, doi. 10.1038/s41408-022-00622-8
- By:
- Publication type:
- Article